123 related articles for article (PubMed ID: 38660802)
1. Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease.
Xu N; Alfieri CM; Yu Y; Guo M; Yutzey KE
Arterioscler Thromb Vasc Biol; 2024 Apr; ():. PubMed ID: 38660802
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
[TBL] [Abstract][Full Text] [Related]
3. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome.
Xu N; Yutzey KE
JACC Basic Transl Sci; 2022 Nov; 7(11):1143-1157. PubMed ID: 36687269
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in mitral valve extracellular matrix, tissue mechanics and function in a mouse model of Marfan syndrome.
Gonzalez BA; Harmeyer SW; Song T; Sadayappan S; Yutzey KE
Matrix Biol; 2024 Feb; 126():1-13. PubMed ID: 38185344
[TBL] [Abstract][Full Text] [Related]
6. Smooth Muscle α-Actin Expression in Mitral Valve Interstitial Cells is Important for Mediating Extracellular Matrix Remodeling.
Dye BK; Butler C; Lincoln J
J Cardiovasc Dev Dis; 2020 Aug; 7(3):. PubMed ID: 32824919
[TBL] [Abstract][Full Text] [Related]
7. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
[TBL] [Abstract][Full Text] [Related]
8. Androgens Accentuate TGF-β Dependent Erk/Smad Activation During Thoracic Aortic Aneurysm Formation in Marfan Syndrome Male Mice.
Tashima Y; He H; Cui JZ; Pedroza AJ; Nakamura K; Yokoyama N; Iosef C; Burdon G; Koyano T; Yamaguchi A; Fischbein MP
J Am Heart Assoc; 2020 Oct; 9(20):e015773. PubMed ID: 33059492
[TBL] [Abstract][Full Text] [Related]
9. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
[TBL] [Abstract][Full Text] [Related]
10. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
[TBL] [Abstract][Full Text] [Related]
11. Localized Prox1 Regulates Aortic Valve Endothelial Cell Diversity and Extracellular Matrix Stratification in Mice.
O'Donnell A; Gonzalez BA; Mukherjee S; Wilson R; Alfieri CM; Swoboda CO; Millay DP; Zorn AM; Yutzey KE
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1478-1493. PubMed ID: 37381982
[TBL] [Abstract][Full Text] [Related]
12. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
13. Multimodality imaging and transcriptomics to phenotype mitral valve dystrophy in a unique knock-in Filamin-A rat model.
Delwarde C; Toquet C; Aumond P; Kayvanjoo AH; Foucal A; Le Vely B; Baudic M; Lauzier B; Blandin S; Véziers J; Paul-Gilloteaux P; Lecointe S; Baron E; Massaiu I; Poggio P; Rémy S; Anegon I; Le Marec H; Monassier L; Schott JJ; Mass E; Barc J; Le Tourneau T; Merot J; Capoulade R
Cardiovasc Res; 2023 May; 119(3):759-771. PubMed ID: 36001550
[TBL] [Abstract][Full Text] [Related]
14. Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.
Thalji NM; Hagler MA; Zhang H; Casaclang-Verzosa G; Nair AA; Suri RM; Miller JD
Circ Cardiovasc Genet; 2015 Jun; 8(3):516-28. PubMed ID: 25814644
[TBL] [Abstract][Full Text] [Related]
15. Statins Reduce Thoracic Aortic Aneurysm Growth in Marfan Syndrome Mice via Inhibition of the Ras-Induced ERK (Extracellular Signal-Regulated Kinase) Signaling Pathway.
Sato T; Arakawa M; Tashima Y; Tsuboi E; Burdon G; Trojan J; Koyano T; Youn YN; Penov K; Pedroza AJ; Shabazzi M; Palmon I; Nguyen MN; Connolly AJ; Yamaguchi A; Fischbein MP
J Am Heart Assoc; 2018 Nov; 7(21):e008543. PubMed ID: 30571378
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm.
Oller J; Gabandé-Rodríguez E; Ruiz-Rodríguez MJ; Desdín-Micó G; Aranda JF; Rodrigues-Diez R; Ballesteros-Martínez C; Blanco EM; Roldan-Montero R; Acuña P; Forteza Gil A; Martín-López CE; Nistal JF; Lino Cardenas CL; Lindsay ME; Martín-Ventura JL; Briones AM; Redondo JM; Mittelbrunn M
Circulation; 2021 May; 143(21):2091-2109. PubMed ID: 33709773
[TBL] [Abstract][Full Text] [Related]
17. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
[TBL] [Abstract][Full Text] [Related]
19. Impaired gait pattern as a sensitive tool to assess hypoxic brain damage in a novel mouse model of atherosclerotic plaque rupture.
Roth L; Van Dam D; Van der Donckt C; Schrijvers DM; Lemmens K; Van Brussel I; De Deyn PP; Martinet W; De Meyer GR
Physiol Behav; 2015 Feb; 139():397-402. PubMed ID: 25449385
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
